BridgeBio Pharma BBIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$166.56M+14.4% | -$194.64M-5.2% | -$184.94M-0.6% | -$183.76M-8.3% | -$169.61M+36.6% | ||
| $1.19M-17.4% | $1.44M+2.6% | $1.4M+6.2% | $1.32M+2.6% | $1.28M-6.1% | ||
| $33.24M-4.0% | $34.64M-1.8% | $35.26M-5.3% | $37.24M+43.9% | $25.88M-14.1% | ||
| $1.82M+25.3% | $1.45M— | —— | —— | $1.62M-21.5% | ||
| $65.78M+187% | $22.93M-42.2% | $39.65M— | —— | $110.54M+2,505% | ||
| $7.05M+262% | $1.95M-71.2% | $6.77M-49.4% | $13.39M+319% | $3.19M— | ||
| -$7.17M-141% | $17.53M— | —— | —— | $17.57M— | ||
| -$37.48M-289% | $19.81M+5.1% | $18.85M+406% | $3.73M+119% | -$19.36M-270% | ||
| $18.85M— | —— | —— | $22.26M+4,470% | $487K— | ||
| $4.62M-81.4% | $24.78M-6.2% | $26.42M+11.7% | $23.66M+704% | $2.95M-72.7% | ||
| -$306K-171% | $434K— | —— | $5.44M+25,819% | $21K— | ||
| -$2.38M-22.1% | -$1.95M+34.8% | -$2.99M+23.8% | -$3.92M-52.5% | -$2.57M-298% | ||
| -$18.28M— | $0— | $0-100% | $15.56M+200% | -$15.56M— | ||
| $1.47M+0.5% | $1.46M— | —— | —— | $994K+0.3% | ||
| $0— | $0— | $0— | $0+100% | -$21.16M— | ||
| -$1.85M-3.5% | -$1.79M-9.1% | -$1.64M+0.4% | -$1.65M-12.0% | -$1.47M-1.9% | ||
| -$197.28M-250% | -$56.42M+48.5% | -$109.57M-35.8% | -$80.68M+59.5% | -$199.24M-2.0% | ||
| $69K+109% | $33K-93.0% | $470K-20.9% | $594K— | $0-100% | ||
| $52.67M+204% | $17.32M— | —— | —— | $0-100% | ||
| $10M— | $0-100% | $2.3M— | $0— | $0— | ||
| $0— | $0-100% | $2.4M-46.7% | $4.5M+182% | $1.6M-50.0% | ||
| -$42.74M-198% | -$14.35M— | —— | -$13M-715% | -$1.6M— | ||
| $82.5M— | —— | —— | —— | $48.28M— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | $459M— | ||
| $22.59M— | $0— | $0— | $0— | $0— | ||
| $0-100% | $600K— | —— | —— | $800K— | ||
| $4.07M-45.2% | $7.43M+146% | $3.03M+51.6% | $2M+12.3% | $1.78M+26.5% | ||
| —— | —— | —— | —— | —— | ||
| $549.89M— | —— | —— | $302.04M+401% | $60.33M-87.3% | ||
| $309.88M+525% | -$72.96M+31.2% | -$106M-151% | $208.36M+248% | -$140.5M-151% | ||
| $20.32M— | —— | $20.4M— | —— | $23.27M+77.6% | ||
| $1.82M+25.3% | $1.45M— | —— | —— | $1.62M-21.5% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $2.16M-74.9% | $8.59M— | —— | —— | $3.95M+155% | ||
| -$18.28M+13.1% | -$21.03M-32.8% | -$15.83M+21.6% | -$20.19M-29.8% | -$15.56M+6.8% | ||
| $12.99M+90.6% | $6.82M+105% | $3.32M+242% | -$2.34M-264% | -$642K— | ||
| -$2.38M-22.1% | -$1.95M+34.8% | -$2.99M+23.8% | -$3.92M-52.5% | -$2.57M-298% | ||
| -$37.48M-289% | $19.81M+5.1% | $18.85M+406% | $3.73M+119% | -$19.36M-270% | ||
| -$1.85M-3.5% | -$1.79M-9.1% | -$1.64M+0.4% | -$1.65M-12.0% | -$1.47M-1.9% | ||
| $1.8M+429% | -$545K+26.5% | -$742K-142% | $1.76M+211% | -$1.59M+19.4% | ||
| $18.85M— | —— | —— | $22.26M+4,470% | $487K— | ||
| $39.87M+3.1% | $38.68M+6.2% | $36.41M+39.9% | $26.03M+8.4% | $24.02M+189% | ||
| $1.47M+0.5% | $1.46M— | —— | —— | $994K+0.3% | ||
| -$306K-171% | $434K— | —— | $5.44M+25,819% | $21K— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $0— | $0-100% | $2.4M-46.7% | $4.5M+182% | $1.6M-50.0% | ||
| $10M+233% | $3M— | —— | —— | $0-100% | ||
| $11.29M+31.9% | $8.56M— | —— | —— | $144K— | ||
| $0-100% | $600K— | —— | —— | $800K— | ||
| $5.47M— | —— | $3.18M— | —— | $3.24M— | ||
| $12K-61.3% | $31K+158% | $12K+104% | -$337K-200% | $337K+6,640% | ||
| $431K— | —— | —— | —— | $0— | ||
| -$1.96M-127% | -$860K+72.2% | -$3.09M-279% | -$816K+1.0% | -$824K+25.1% | ||
| $0— | —— | —— | —— | $4.5M— | ||
| -$197.35M-250% | -$56.45M+48.7% | -$110.04M-35.4% | -$81.28M+59.2% | -$199.24M-2.0% | ||
| -$197.35M-250% | -$56.45M+48.7% | -$110.04M-35.4% | -$81.28M+59.2% | -$199.24M-2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
